s6y
Company name or ticker
Search
Oncotelic Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Tuesday, April 3, 2012
Accession number
0001193125-12-148094
Documents
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
POS AM
CONSENT OF ERNST & YOUNG LLP
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header